These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29449047)

  • 1. Validation and update of a lymph node metastasis prediction model for breast cancer.
    Qiu SQ; Aarnink M; van Maaren MC; Dorrius MD; Bhattacharya A; Veltman J; Klazen CAH; Korte JH; Estourgie SH; Ott P; Kelder W; Zeng HC; Koffijberg H; Zhang GJ; van Dam GM; Siesling S
    Eur J Surg Oncol; 2018 May; 44(5):700-707. PubMed ID: 29449047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
    Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
    BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
    Murphy BL; L Hoskin T; Heins CDN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 Sep; 24(9):2518-2525. PubMed ID: 28484921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.
    Qiu SQ; Zeng HC; Zhang F; Chen C; Huang WH; Pleijhuis RG; Wu JD; van Dam GM; Zhang GJ
    Sci Rep; 2016 Feb; 6():21196. PubMed ID: 26875677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
    Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasound.
    Meretoja TJ; Heikkilä PS; Mansfield AS; Cserni G; Ambrozay E; Boross G; Zgajnar J; Perhavec A; Gazic B; Arisio R; Tvedskov TF; Jensen MB; Leidenius MH
    Ann Surg Oncol; 2014 Jul; 21(7):2229-36. PubMed ID: 24664623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict the probability of axillary lymph node metastasis in female patients with breast cancer in China: A nationwide, multicenter, 10-year epidemiological study.
    Zhang J; Li X; Huang R; Feng WL; Kong YN; Xu F; Zhao L; Song QK; Li J; Zhang BN; Fan JH; Qiao YL; Xie XM; Zheng S; He JJ; Wang K
    Oncotarget; 2017 May; 8(21):35311-35325. PubMed ID: 27852049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.
    van den Hoven I; Kuijt G; Roumen R; Voogd A; Steyerberg EW; Vergouwe Y
    J Surg Oncol; 2015 Aug; 112(2):133-8. PubMed ID: 26258749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
    Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
    J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.